Home
Storia in 1 fonti
Novo Nordisk's less-bad news on its Wegovy pill boosts earnings and share price
Vivek Ramaswamy wins GOP primary for Ohio governor, CellCentric raises $220M for myeloma drug, and more biotech news
Raccontata da
statnews.com
- ·
Are analysts too quick to gloss over Lilly's liver case?
Cytokinetics' Myqorzo's trial results, Johnson & Johnson's IBD therapy, and more biotech news from The Readout
- ·
Novo Nordisk's less-bad news on its Wegovy pill boosts earnings and share price
Vivek Ramaswamy wins GOP primary for Ohio governor, CellCentric raises $220M for myeloma drug, and more biotech news